Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Entrectinib by F. Hoffmann-La Roche for High-Grade Glioma: Likelihood of Approval
Entrectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for High-Grade Glioma. According to GlobalData,...
Entrectinib by F. Hoffmann-La Roche for Metastatic Pancreatic Cancer: Likelihood of Approval
Entrectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Metastatic Pancreatic Cancer. According to...
Entrectinib by F. Hoffmann-La Roche for Neuroblastoma: Likelihood of Approval
Entrectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Neuroblastoma. According to GlobalData, Phase...